|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical,cellular,and molecular factors that contribute to antifungal drug resistance显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 2 | Clinical,cellular,and molecularfactors that coritribute to antifungal drug resistance显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Micro-biol Rev1998，11，2： | 1 |
| 3 | Hairpin dsRNA does not trigger RNA interference in Candida albicaru ceils 显示文摘 | Staab JF White TC Marr KA | 2011 | Yeast2011，28，1： | 1 |
| 4 | Organophosphate- induced intermediate syndrome: aetiology and relationships with myopathy显示文摘 | KARAL LIEDDE L BAKER D MARRS TC | 2006 | Toxicol Rev2006，25，1： | 1 |
| 5 | Variables influencing thetoxic response to organophosphates in humans显示文摘 | Karalliedde LD Edwards P Marrs TC | 2003 | Food ChemToxicol2003，41，1： | 1 |
| 6 | Clinical, cellular, and molecular factors that contribute to antifimgal drug resistance 显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 7 | Clinical, cellular, and molec- ular factors that contribute to antifungal drug resistance 显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 8 | Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole显示文摘 | Marr KA Seidel K White TC | 2000 | J Infect Dis2000，181，1： | 1 |
| 9 | Clinical, celluar, and molecular factor that contribute to antifungal drug resistance 显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 10 | Clinical, cellular, and molecular factors that contribute to antifungal drug resistance 显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 11 | Clinical,cellular,and molecular factors that contribute to antifungal drug resistance显示文摘 | White TC Marr KA Bowden RA | | 0，，02： | 1 |
| 12 | Clinical,cellular and molecular factors that contribute to antifungal drug resistance显示文摘 | Marr KA Bowden RA | 1998 | Clin Microbial Rev1998，11，： | 1 |
| 13 | Clinical cellular and molecular factors that contribute to antifungal drug resistance 显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 14 | Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole 显示文摘 | Marr KA Seidel K White TC | 2000 | J Infect Dis2000，181，： | 1 |
| 15 | Clinical cellular and molecu- lar factors that contribute to antifungal drug resistance显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 16 | Organophosphate-indueed intermediate syndrome: aetiology and relationships with myopathy显示文摘 | KARALLIEDDE L BAKER D MARRS TC | 2006 | Toxicol Rev2006，25，1： | 1 |
| 17 | Clinical, cellular, and molec- ular factors that contribute to antifungal drug resistance显示文摘 | White TC Marr KA Bowden RA | 1998 | Clin MicrobiolRev1998，11，1： | 1 |
| 18 | Clinical, cellular and molecular factors that contribute to antifungal drug resistance 显示文摘 | WHITE TC MARR KA BOWDEN RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
| 19 | Clinical,cellular,and molecular factors that contribute to antifungal drug resistance显示文摘 | White TC Marr KA Boweden RA | | 0，，02： | 1 |
| 20 | Clinical,cellular,and molecular factors that contribute to antifungal drug resistance显示文摘 | Marr KA Bowden RA | 1998 | Clin Microbiol Rev1998，11，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员